Evaline Tsai net worth
Quick answer
Evaline Tsai's estimated net worth is $19K (range $13K – $28K) as of 2026. Evaline Tsai is CPO at Cambridge Cancer Genomics. Cambridge Cancer Genomics valuation.
Evaline Tsai is CPO at Cambridge Cancer Genomics (YC S17). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Inactive
- Region: United States of America
- Industries: Healthcare, Diagnostics
- Team size: 25
- Website: http://ccg.ai
Who is Evaline Tsai?
Evaline Tsai is a co-founder of Cambridge Cancer Genomics, which was part of Y Combinator S17.
Highlights:
- Y Combinator S17
- Cambridge Cancer Genomics
About Cambridge Cancer Genomics
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions...
FAQ: Evaline Tsai net worth and Cambridge Cancer Genomics valuation
What is Evaline Tsai's net worth?
Evaline Tsai's estimated net worth is $19K (range $13K – $28K) as of 2026. Evaline Tsai is CPO at Cambridge Cancer Genomics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Cambridge Cancer Genomics valuation?
Cambridge Cancer Genomics's estimated valuation on Entrepreneurial Check is $1.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Evaline Tsai's role?
Evaline Tsai is CPO at Cambridge Cancer Genomics, a Y Combinator-backed startup (batch S17).